Hidradenitis Suppurativa clinical and non-clinical studies, key companies, treatment evaluation, emerging therapies, treatment algorithms, and pipeline analysis | InflaRx, Novartis, UCB, ChemoCentryx, Eli Lilly and Company, Janssen Biotech, AbbVie, Pfizer | #health